872 results on '"Barnes, Edward L"'
Search Results
2. The Management of Postoperative Recurrence in Crohn’s Disease
3. Suboptimal Guideline Adherence and Biomarker Underutilization in Monitoring of Post-operative Crohn’s Disease
4. Antibiotic Use in the 12 Months Prior to Ileal Pouch-Anal Anastomosis Increases the Risk for Pouchitis
5. Acute Kidney Injury in Inflammatory Bowel Disease Patients: A Nationwide Comparative Analysis
6. Very Early Pouchitis Is Associated with an Increased Likelihood of Chronic Inflammatory Conditions of the Pouch
7. Lower Extremity Palpable Purpura in a Patient with Quiescent Inflammatory Bowel Disease
8. Real-World Surgical and Endoscopic Recurrence Based on Risk Profiles and Prophylaxis Utilization in Postoperative Crohn’s Disease
9. Comparative Effectiveness of Upadacitinib vs Ustekinumab for Ulcerative Colitis: A Multicenter Retrospective Cohort Study
10. Extraintestinal Manifestations and Family History of Inflammatory Bowel Disease Increase the Risk of Pouchitis in a State-Level Epidemiology Study
11. AGA Clinical Practice Guideline on the Management of Pouchitis and Inflammatory Pouch Disorders
12. Development of an Inflammatory Bowel Disease-Specific Medication Adherence Instrument and Reasons for Non-adherence
13. An Old Bridge to the Newer Biologics: Cyclosporine for Rescue Therapy in Acute Severe Ulcerative Colitis
14. Comparative Safety of Biologic Agents in Patients With Inflammatory Bowel Disease With Active or Recent Malignancy: A Multi-Center Cohort Study
15. Development of the Endoscopic Pouch Score for Assessment of Inflammatory Conditions of the Pouch
16. Disease Monitoring of the Ileoanal Pouch: How to Utilize Biomarkers, Imaging, and Pouchoscopy
17. Relationship Between Stages of Ileal Pouch-Anal Anastomosis, Timing of Restoration of Fecal Continuity, and Pouchitis
18. Off the Cuff Markers: Surveillance and Endoscopic Approaches for Dysplasia After Ileal Pouch-Anal Anastomosis
19. Quality of Care in the Management of Hospitalized Patients with Inflammatory Bowel Disease
20. Prevalence of Immunomodulator Use as Combination Therapy With Vedolizumab or Ustekinumab in Inflammatory Bowel Disease
21. Patient Reported Outcome Assessments Used in the Evaluation of Patients after Ileal Pouch-Anal Anastomosis: A Systematic Review
22. Increasing Incidence of Pouchitis Between 1996 and 2018: A Population-Based Danish Cohort Study
23. Diagnosis of Inflammatory Bowel Disease–Associated Peripheral Arthritis: A Systematic Review
24. Patients With Pouchitis Demonstrate a Significant Cost Burden in the First Two Years After Ileal Pouch-Anal Anastomosis
25. Test Characteristics of Cross-sectional Imaging and Concordance With Endoscopy in Postoperative Crohn’s Disease
26. Predictors and Outcomes of Ustekinumab Dose Intensification in Ulcerative Colitis: A Multicenter Cohort Study
27. Treating IBD? Don’t Forget that Mental Health Matters
28. Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD
29. Change in Biologic Class Promotes Endoscopic Remission Following Endoscopic Postoperative Crohn's Disease Recurrence.
30. Efficacy and Safety of Liraglutide in Patients With an Ileal Pouch-Anal Anastomosis and Chronic High Bowel Frequency: A Placebo-Controlled, Crossover, Proof-of-Concept Study.
31. Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021
32. Postoperative Use of Biologics Was Less Common Among Patients With Crohn’s Disease With Emergent/Urgent vs Elective Intestinal Resection
33. Single-Cell Analysis Reveals Unexpected Cellular Changes and Transposon Expression Signatures in the Colonic Epithelium of Treatment-Naïve Adult Crohn’s Disease Patients
34. Development and Validation of a Symptom Based Scoring System for Bowel Dysfunction after Ileoanal Pouch Reconstruction: The Ileoanal Pouch Syndrome Severity Score
35. Reply to Dai, Huang, and Jiang
36. Endoscopic assessment of the J pouch in ulcerative colitis: A narrative review
37. Efficacy and safety of liraglutide in patients with patients with an ileal pouch-anal anastomosis and chronic high bowel frequency: A placebo-controlled, crossover, proof of concept study
38. One-Year Comparative Effectiveness of Upadacitinib vs Tofacitinib for Ulcerative Colitis: A Multicenter Cohort Study
39. Response to Lin and Wei
40. Patients With Inflammatory Bowel Disease Are at Increased Risk of Hospitalization Due to Respiratory Syncytial Virus
41. Personalized Best: Toward Improving Care in Ulcerative Colitis
42. Incidence, Risk Factors, and Outcomes of Pouchitis and Pouch-Related Complications in Patients With Ulcerative Colitis
43. Quality of Care in the Management of Hospitalized Patients with Inflammatory Bowel Disease
44. Creation of a Case-Finding Definition for Identifying Patients With Acute Pouchitis in Administrative Claims Data
45. Drug-induced liver injury associated with lopinavir-ritonavir in patients with COVID-19: a disproportionality analysis of U.S. food and drug administration adverse event reporting system (FAERS) data
46. Same Day Infusion of Iron Therapy Is Associated With No Increased Risk for Adverse Events Among Patients Receiving Biological Infusions for Inflammatory Bowel Disease
47. The Cumulative Incidence of Pouchitis in Pediatric Patients With Ulcerative Colitis
48. Extensive Colitis and Smoking Are Associated With Postoperative Complications Within 30 Days of Ileal Pouch–Anal Anastomosis.
49. A Practical Guide to the Use of Upadacitinib in Ulcerative Colitis and Crohn's Disease.
50. Clinical and Endoscopic Outcomes After Upadacitinib Induction for Ulcerative Colitis: A Multicenter Retrospective Cohort Study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.